Skip to main content

DTC · Defence Therapeutics Inc · Insider Trading

0.355 CAD +0.005 (+1.43%) At close · Nov 6 Intraday price with Plus
Market Cap
27.02M CAD
Shares
76.11M
Volume · Nov 6 18.23K Avg daily vol (3M) 47.26K

Transactions in Defence Therapeutics Inc securities by its insiders (directors, officers and significant shareholders) as filed on SEDI, the Canadian Securities Administrators' insider disclosure system.

Insider transactions

Insider transactions as filed on SEDI, each amended transaction at its newest amendment only. Capture began with about the year before its first read and grows daily, so older history is not included. Amounts are signed (negative for a disposition) and counted in the units of the security named, which may be options, share units or warrants rather than shares. Prices are in the stated currency. Holding after is the insider's balance of that security after the transaction, as filed.

Insider transactions filed on SEDI, the Canadian Securities Administrators' System for Electronic Disclosure by Insiders
Transaction dateInsiderTransactionSecurityAmountPriceHolding afterFiled
2026-10-22 Lambermon-Phinney, Amie Lynn Director of Issuer Acquisition or disposition in the public market Common Shares +4,333 0.3942 CAD 16,333Direct 2026-10-23
2026-10-19 Lambermon-Phinney, Amie Lynn Director of Issuer Acquisition or disposition in the public market Common Shares +12,000 0.38 CAD 12,000Direct 2026-10-23
2026-09-29 Aulin, Sherry Director of Issuer Grant of options OptionsUnderlying: Common Shares +400,000 400,000Direct 2026-10-01
2026-09-29 Aulin, Sherry Director of Issuer Opening Balance-Initial SEDI Report OptionsUnderlying: Common Shares 0 Direct 2026-10-01
2026-09-24 Lambermon-Phinney, Amie Lynn Director of Issuer Grant of rights Restricted Stock UnitsUnderlying: Common Shares +3,500,000 3,500,000Direct 2026-10-01
2026-09-24 Plouffe, Sébastien Director of Issuer Grant of rights Rights Restricted share unitsUnderlying: Common Shares +3,500,000 3,500,000Direct 2026-09-29
2026-08-01 Lambermon-Phinney, Amie Lynn Director of Issuer Grant of options OptionsUnderlying: Common Shares +200,000 350,000Direct 2026-08-06
2026-08-01 Plouffe, Sébastien Director of Issuer Grant of options OptionsUnderlying: Common Shares +200,000 1,600,000Direct 2026-08-05
2026-06-01 Lambert, John Martin Director of Issuer Opening Balance-Initial SEDI Report OptionsUnderlying: Common Shares 0 150,000Direct 2026-06-09
2026-04-30 Plouffe, Sébastien Director of Issuer Exercise of rights Common Shares +200,000 1,800,000Direct 2026-05-03
2026-04-30 Plouffe, Sébastien Director of Issuer Exercise of rights Rights Restricted share unitsUnderlying: Common Shares -200,000 0Direct 2026-05-03
2026-04-24 Plouffe, Sébastien Director of Issuer Grant of rights Rights Restricted share unitsUnderlying: Common Shares +200,000 200,000Direct 2026-04-28
2026-03-06 Rifai, Omar 10% Security Holder of Issuer Acquisition or disposition under a prospectus exemption WarrantsUnderlying: Common Shares +5,000,000 5,750,000Direct 2026-03-27
2026-03-06 Rifai, Omar 10% Security Holder of Issuer Opening Balance-Initial SEDI Report WarrantsUnderlying: Common Shares 0 750,000Direct 2026-03-27
2026-03-06 Rifai, Omar 10% Security Holder of Issuer Acquisition or disposition under a prospectus exemption Common Shares +5,000,000 0.55 CAD 5,750,000Direct 2026-03-27
2026-03-06 Rifai, Omar 10% Security Holder of Issuer Opening Balance-Initial SEDI Report Common Shares 0 750,000Direct 2026-03-27
2025-12-10 Selivanova, Svetlana Director of Issuer Grant of options OptionsUnderlying: Common Shares +50,000 150,000Direct 2025-12-16
2025-12-10 Lambermon-Phinney, Amie Lynn Director of Issuer Grant of options OptionsUnderlying: Common Shares +50,000 150,000Direct 2025-12-16
2025-12-10 Plouffe, Sébastien Director of Issuer Grant of optionsAmendment 1 OptionsUnderlying: Common Shares +400,000 1,400,000Direct 2025-12-15
2025-12-10 Lefrancois, Philippe Director of Issuer · Held by Gestion Philippe Lefrancois Inc. Grant of optionsAmendment 1 OptionsUnderlying: Common Shares +50,000 150,000Indirect 2025-12-11
2025-12-10 Meterissian, Sarkis Director of Issuer Grant of options OptionsUnderlying: Common Shares +200,000 450,000Direct 2025-12-11

21 transactions between 2025-12-10 and 2026-10-22. Checked 2026-11-08 17:12 UTC.

Showing 1–21 of 21 transactions